Systemic Inflammation in Metabolic Syndrome: Increased Platelet and Leukocyte Activation, and Key Role of CX3CL1/CX3CR1 and CCL2/CCR2 Axes in Arterial Platelet-Proinflammatory Monocyte Adhesion

Abstract

Background: Metabolic syndrome is associated with low-grade systemic inflammation, which is a key driver of premature atherosclerosis. We characterized immune cell behavior in metabolic syndrome, its consequences, and the potential involvement of the CX3CL1/CX3CR1 and CCL2/CCR2 chemokine axes. Methods: Whole blood from 18 patients with metabolic syndrome and 21 age-matched controls was analyzed by flow cytometry to determine the leukocyte immunophenotypes, activation, platelet-leukocyte aggregates, and CX3CR1 expression. ELISA determined the plasma marker levels. Platelet-leukocyte aggregates adhesion to tumor necrosis factor-α (TNFα)-stimulated arterial endothelium and the role of CX3CL1/CX3CR1 and CCL2/CCR2 axes was investigated with the parallel-plate flow chamber. Results: When compared with the controls, the metabolic syndrome patients presented greater percentages of eosinophils, CD3+ T lymphocytes, Mon2/Mon3 monocytes, platelet-eosinophil and -lymphocyte aggregates, activated platelets, neutrophils, eosinophils, monocytes, and CD8+ T cells, but lower percentages of Mon1 monocytes. Patients had increased circulating interleukin-8 (IL-8) and TNFα levels and decreased IL-4. CX3CR1 up-regulation in platelet-Mon1 monocyte aggregates in metabolic syndrome patients led to increased CX3CR1/CCR2-dependent platelet-Mon1 monocyte adhesion to dysfunctional arterial endothelium. Conclusion: We provide evidence of generalized immune activation in metabolic syndrome. Additionally, CX3CL1/CX3CR1 or CCL2/CCR2 axes are potential candidates for therapeutic intervention in cardiovascular disorders in metabolic syndrome patients, as their blockade impairs the augmented arterial platelet-Mon1 monocyte aggregate adhesiveness, which is a key event in atherogenesis.

Dietary-Induced Low-Grade Inflammation in the Liver

“…In our work, determined hepatic expression levels of cytokines do not provide a homogeneous pattern. According to TNFα elevations in obesity shown by other working groups [ 10 , 39 , 44 ], we were able to show an elevation of hepatic TNFα expression in the HFD group too, but also in the CD group compared to the SD group. Whilst the expression of pro-inflammatory TNFα was in line with the shown cellular immune response, the results of the other three analyzed cytokines differed and were partially contradictory.…”

Electrochemical sensing: A prognostic tool in the fight against COVID-19

“…Metabolic syndrome and its associated illnesses are commonly accompanied by chronic systemic inflammation, which overloads patients’ immune and cardiovascular systems [ 13 ] [ 198 ]. In COVID-19 patients this is compounded by the inflammation from the infection, and the excess of inflammatory cytokines can lead to a fatal cytokine storm [ 199 ].…”

Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects

“…Again, E2 has been reported to directly downregulate the expression of CCL2 in all leukocytes to reduce their migration to the infection site. Recruitment of leukocytes to the site of infection can result in severe inflammation and tissue damage [ 61 , 62 ]. Hence, estrogen's ability to induce anti-inflammatory responses is an indication that hyperestrogenemic females are better protected against severe inflammation than their male counterparts.…”